This highly responsive trainer has a performance fit and was developed for runners seeking premium cushioning and a moderate level of stability. The successor to the popular 760, the lightweight 860 features a dual density medial post, ABZORB® in the forefoot and advanced N-ergy® cushioning in the heel to give serious runners an edge.

New Balance will contribute 5% of the suggested retail price of sales from the Lace Up for the Cure® Collection with a guaranteed minimum donation of $500,000 each year to Susan G. Komen® through 2012.

The Running Ribbon and Lace Up for the Cure® are registered trademarks of Susan G. Komen®.

	N-ERGY® in the midsole provides NB's most advanced shock absorption and cushioning
	ACTEVA™ LITE premium lightweight midsole provides optimal resistance to compression set - 24% lighter than standard foam
	STABILITY WEB® delivers midfoot support and reduces the weight of the shoe
	ABZORB® cushioning in the midfoot provides exceptional shock absorption
	Medicare / HCPCS code = A5500 Diabetic shoe
	Ndurance® rubber compound for maximum outsole durability
	Dual density medial post
	Forefoot Flex Grooves allow extreme flexibility
	Synthetic/Mesh upper provides lightweight comfort and support